(WOODLAND HILLS, CA) – April 9th, 2025 – Scientists at Terasaki Institute for Biomedical Innovation, in collaboration with the University of Maryland School of Pharmacy, have developed a new nanoparticle therapy that tackles obesity through two complementary mechanisms: converting energy-storing white fat into calorie-burning beige fat while simultaneously reducing obesity-related inflammation. Their findings, published in the Journal of Controlled Release, are detailed in an article titled: “Apigenin-loaded nanoparticles for obesity intervention through immunomodulation and adipocyte browning.” This innovative approach addresses key limitations of current obesity treatments by precisely targeting adipose tissue with apigenin-loaded nanoparticles - enhancing therapeutic effects while minimizing potential side effects. A link to the article can be found here.